Phase I study of Pomolidomide, Bortezomib, and Dexamethasone (PVD) as First-Line treatment of AL Amyloidosis or Light Chain Deposition Disease

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2014 - December 1, 2021